Chaser Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Chaser Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| PBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDS (NCT07761533) | Chaser Therapeutics, Inc. | 2025-09-08 |
Track Chaser Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.